Monday, April 11, 2022

New Clinical Trial of Cell Replacement in Parkinson’s Disease

New Clinical Trial of Cell Replacement in Parkinson’s Disease - Aspen Neuroscience, Inc. announced that this month it will launch the first patient screening study of its kind, working with multiple clinical screening sites in the U.S. The company’s Trial-Ready Cohort Study is a preliminary step to filing an Investigational New Drug (IND) application with the US Food & Drug Administration for ANPD001, its first therapeutic development candidate for potential treatment of idiopathic Parkinson’s disease (PD). The Trial-Ready Cohort Study will provide information to and screen potential patient candidates for […] Click here to read: eTurboNews | TravelNews | World Talk
http://dlvr.it/SNPlM5

No comments:

Post a Comment